Cargando…
Serum HMGB1 Serves as a Novel Laboratory Indicator Reflecting Disease Activity and Treatment Response in Ankylosing Spondylitis Patients
Objective. High mobility group box 1 (HMGB1) is a late inflammatory factor participating in the pathogenesis of various autoimmune and inflammatory diseases. In the current study, we analyzed the association between serum levels of HMGB1 and clinical features of AS patients before and during treatme...
Autores principales: | Wang, Chenqiong, Miao, Ye, Wu, Xuefen, Huang, Yishu, Sun, Mengchen, Zhu, Yingzi, Zheng, Fang, Sun, Wei, Dong, Lingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5069358/ https://www.ncbi.nlm.nih.gov/pubmed/27800496 http://dx.doi.org/10.1155/2016/6537248 |
Ejemplares similares
-
Elevated Serum Levels of Soluble CD30 in Ankylosing Spondylitis Patients and Its Association with Disease Severity-Related Parameters
por: Gao, Rongfen, et al.
Publicado: (2015) -
Detection of Serum IgG4 Levels in Patients with IgG4-Related Disease and Other Disorders
por: Su, Yuying, et al.
Publicado: (2015) -
Ankylosing spondylitis
Publicado: (1980) -
Ankylosing spondylitis
por: Edavalath, Mukesh
Publicado: (2010) -
Ankylosing Spondylitis
por: Whitfield, A. G. W.
Publicado: (1976)